Selling to a DSO Isn't Just "Selling to a Bigger Practice" | NPLUS Global

We used to treat DSO outreach like independent practice outreach with more zeros attached. Same pitch, same cadence, just aimed at a bigger mailbox. That assumption cost us more deals than we'd like to admit, and it took a few painfully quiet quarters to figure out why. The short version: you're not selling a bigger version of the same thing. You're selling to a completely different kind of organization that happens to also have "dental" or "dermatology" in its name.

Who's Actually on the Other End of the Line

With an independent practice, you're usually talking to someone who touches the clinical floor, signs the checks, and decides what gets installed in the office — sometimes all in the same fifteen-minute conversation. There's an owner-operator logic to it. Even when there's an office manager buffering the doctor, that person still has a direct line to the person whose name is on the building.

A DSO strips that intimacy out almost entirely. The person deciding whether your product gets piloted might sit two states away from any of the practices it'll actually touch. You're often navigating a stack of roles that didn't exist ten years ago — VP of Clinical Operations, Director of Revenue Cycle, someone with "Growth" in their title who's never set foot in an operatory. None of them experience the day-to-day pain the way a solo practice owner does, and that changes what "pain" even means to them. A missed patient callback is a nuisance to an independent doctor. To a DSO exec, it's a line item in a leakage report affecting sixty locations, and they want to see the aggregate number before they care about the anecdote.

We had a rep who spent three calls trying to sell a DSO regional director on "how much time this saves your front desk staff." Reasonable pitch — for an independent office. The director finally said something like, "I don't manage front desk staff, I manage a P&L across four states." That was the moment it clicked for us: the DSO buyer isn't evaluating a tool, they're evaluating a variable in a much bigger operating model.

The Pitch Has to Change Altitude, Not Just Volume

This is where a lot of outbound strategy quietly fails. Teams assume that selling to a DSO just means saying "scalable" more often and mentioning that the tool "works across multiple locations." That's decoration, not strategy. The real shift is altitude — you have to zoom out from clinical or operational benefit and land on financial and standardization benefit instead.

Independent practices respond to specificity: this will save Dr. Patel's staff four hours a week, this will reduce no-shows in a single 1,500-patient panel. DSOs respond to consistency and defensibility: can this be rolled out identically across ninety locations without forty different IT tickets, does it integrate with the practice management system they've already standardized on, will it survive a change in ownership if the DSO gets acquired next year (which, in this space, is not a hypothetical).

We've also noticed DSO buyers are far more skeptical of vendor claims by default — not because they're harder people, but because they've been burned by point solutions that worked great in a pilot location and fell apart at scale. Independent practices are more forgiving of "let's just try it and see." DSOs want proof it's been done at their scale, ideally in their vertical, ideally with a name they recognize, before they'll even take a second call.

Timing Runs on a Completely Different Clock

Independent practice sales cycles move on personal bandwidth — how busy the doctor is this month, whether the office manager is dealing with a staffing hole, whether it's tax season. Annoying, but at least it's human and somewhat readable.

DSO cycles move on budget architecture. If you're not aware of when their fiscal year turns over, when regional leadership does quarterly business reviews, or when a private equity refresh is scheduled to happen, you'll waste months pushing on a door that was never going to open outside its designated window. We've seen deals that looked completely dead in March come back to life in October simply because that's when next year's vendor budget got unlocked. Nothing about the pitch changed. The calendar did.

This also means your outbound cadence needs patience baked in differently. With an independent practice, silence after three touches usually means "not interested" or "too busy, try again in two months." With a DSO, silence might just mean your contact is waiting on a budget cycle, a leadership change, or sign-off from someone you don't even have a name for yet. Persistence reads as pushy in one context and as simply understanding-how-procurement-works in the other.

What We Actually Do Differently Now

Practically, this means our data segmentation for outbound has to separate DSO-affiliated locations from independents well before messaging gets written — not as an afterthought, but as the first filter. At NPLUS Global we've found that even something as basic as correctly attributing a location to its parent DSO changes the entire sequencing logic downstream: who gets contacted, in what order, with what framing, and on what timeline.

The uncomfortable truth is that most outbound playbooks are still written with the independent practice as the default mental model, because that's historically been the easier sale and the more familiar buyer. DSOs get treated like a scaled-up version of that same playbook instead of the structurally different animal they are. The teams that figure this out early stop wasting cycles pitching efficiency to someone who thinks in EBITDA, and start having the conversation the buyer actually wants to have. It's a smaller shift than it sounds, and it's also the whole game.